Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.


OBJECTIVES To evaluate levetiracetam (LEV) tolerability in patients with epilepsy and liver disease. METHODS Fourteen patients with epilepsy and concomitant liver disease were treated with LEV in an open prospective investigation mimicking the daily clinical practice. All patients were stabilized (ie, for at least 1 year) on traditional antiepileptic… (More)
DOI: 10.1097/WNF.0b013e31815c1d92


  • Presentations referencing similar topics